Literature DB >> 7614252

An HSV-1 containing the rat beta-glucuronidase cDNA inserted within the LAT gene is less efficient than the parental strain at establishing a transcriptionally active state during latency in neurons.

S L Deshmane1, T Valyi-Nagy, T Block, J Maggioncalda, J H Wolfe, A Dillner, N W Fraser.   

Abstract

The herpes simplex virus vector 17/LAT-RGUSB has previously been shown to express beta-glucuronidase enzyme activity stably in the trigeminal ganglia and brain stems of beta-glucuronidase-deficient mutant mice. However, the number of beta-glucuronidase expressing cells in trigeminal ganglia latently infected with 17/LAT-RGUSB was smaller than expected. Using normal mice for further characterization of 17/LAT-RGUSB latent infection, no appreciable differences were found between the vector and wild-type virus in: (1) their abilities to replicate in acutely infected ganglia; (2) their abilities to reactivate from latently infected ganglia: or (3) the quantities of viral DNA in tissues during the acute or the latent phases of infection. Using a minor LAT (mLAT)-specific probe to detect transcription by in situ hybridization, it was found that the intensity of the signal from individual cells latently-infected with 17/LAT-RGUSB or wild-type virus was similar. However, the vector-infected ganglia had only 20% as many positive cells as in wild-type infection. These data suggest that 17/LAT-RGUSB virus established latency similarly to wild-type virus, but that the LAT-promoter driven gene expression was compromised.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7614252

Source DB:  PubMed          Journal:  Gene Ther        ISSN: 0969-7128            Impact factor:   5.250


  6 in total

Review 1.  Herpes simplex virus-based vectors.

Authors:  Robin Lachmann
Journal:  Int J Exp Pathol       Date:  2004-10       Impact factor: 1.925

2.  Utilization of the herpes simplex virus type 1 latency-associated regulatory region to drive stable reporter gene expression in the nervous system.

Authors:  R H Lachmann; S Efstathiou
Journal:  J Virol       Date:  1997-04       Impact factor: 5.103

3.  The latency-associated promoter of herpes simplex virus type 1 requires a region downstream of the transcription start site for long-term expression during latency.

Authors:  J R Lokensgard; H Berthomme; L T Feldman
Journal:  J Virol       Date:  1997-09       Impact factor: 5.103

4.  Construction of a herpes simplex virus type 1 mutant with only a three-nucleotide change in the branchpoint region of the latency-associated transcript (LAT) and the stability of its two-kilobase LAT intron.

Authors:  Alan K Ng; Timothy M Block; Benjamas Aiamkitsumrit; Mengjun Wang; Emily Clementi; Ting-Ting Wu; John M Taylor; Ying-Hsiu Su
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

5.  Infection and establishment of latency in the dog brain after direct inoculation of a nonpathogenic strain of herpes simplex virus-1.

Authors:  S L Springer; C H Vite; A C Polesky; S Kesari; N W Fraser; J H Wolfe
Journal:  J Neurovirol       Date:  2001-04       Impact factor: 2.643

6.  Bilateral single-site intracerebral injection of a nonpathogenic herpes simplex virus-1 vector decreases anxiogenic behavior in MPS VII mice.

Authors:  Wenpei Liu; Gerald Griffin; Trena Clarke; Michael K Parente; Rita J Valentino; John H Wolfe; Nigel W Fraser
Journal:  Mol Ther Methods Clin Dev       Date:  2015-01-28       Impact factor: 6.698

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.